Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
5.26
0.00 (0.00%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Journey Medical Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Market Capitalization | 144 | 209 | 82 | 107 | 34 | 90 | Upgrade
|
| Market Cap Growth | 3.19% | 156.14% | -23.38% | 212.54% | -61.94% | - | Upgrade
|
| Enterprise Value | 145 | 210 | 80 | 85 | 25 | 109 | Upgrade
|
| Last Close Price | 5.26 | 7.71 | 3.91 | 5.76 | 1.92 | 5.38 | Upgrade
|
| PS Ratio | 2.32 | 3.38 | 1.46 | 1.35 | 0.46 | 1.42 | Upgrade
|
| PB Ratio | 4.48 | 6.57 | 4.07 | 5.24 | 2.01 | 2.13 | Upgrade
|
| P/TBV Ratio | 33.85 | 49.26 | - | 1692.20 | - | 3.04 | Upgrade
|
| P/FCF Ratio | - | - | - | 20.35 | - | - | Upgrade
|
| P/OCF Ratio | - | - | - | 20.35 | - | - | Upgrade
|
| EV/Sales Ratio | 2.35 | 3.39 | 1.43 | 1.07 | 0.33 | 1.73 | Upgrade
|
| EV/EBITDA Ratio | - | - | - | 17.57 | - | - | Upgrade
|
| EV/EBIT Ratio | - | - | - | 79.43 | - | - | Upgrade
|
| EV/FCF Ratio | - | - | - | 16.22 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.80 | 0.80 | 1.28 | 0.87 | 1.57 | 0.22 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | 3.59 | - | - | Upgrade
|
| Debt / FCF Ratio | - | - | - | 3.38 | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.04 | 0.04 | 0.27 | -0.48 | -0.32 | -0.95 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.33 | -0.33 | -0.53 | -2.01 | 0.23 | 2.45 | Upgrade
|
| Net Debt / FCF Ratio | -0.10 | -0.10 | -0.59 | -1.85 | 0.40 | 18.36 | Upgrade
|
| Asset Turnover | 0.71 | 0.71 | 0.72 | 0.87 | 0.73 | 0.85 | Upgrade
|
| Inventory Turnover | 1.74 | 1.74 | 1.70 | 1.88 | 2.56 | 4.54 | Upgrade
|
| Quick Ratio | 1.44 | 1.44 | 0.87 | 1.02 | 0.90 | 1.40 | Upgrade
|
| Current Ratio | 1.79 | 1.79 | 1.37 | 1.35 | 1.16 | 1.64 | Upgrade
|
| Return on Equity (ROE) | -44.03% | -44.03% | -72.60% | -20.64% | -100.39% | -168.12% | Upgrade
|
| Return on Assets (ROA) | -5.84% | -5.84% | -10.88% | 0.73% | -16.99% | -15.79% | Upgrade
|
| Return on Invested Capital (ROIC) | -27.51% | -27.88% | -75.75% | 9.62% | -404.39% | -170.38% | Upgrade
|
| Return on Capital Employed (ROCE) | -14.30% | -14.30% | -30.30% | 3.10% | -71.80% | -41.30% | Upgrade
|
| Earnings Yield | -7.95% | -5.46% | -17.96% | -3.61% | -86.86% | -49.09% | Upgrade
|
| FCF Yield | -8.65% | -5.95% | -11.17% | 4.92% | -39.68% | -2.43% | Upgrade
|
| Buyback Yield / Dilution | -19.90% | -19.90% | -12.06% | -4.00% | -72.05% | 5.96% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.